Our results show that combined mutations on Vav1 and Themis induces a strong reduction of the severity of Experimental Autoimmune Encephalomyelitis (EAE), a mouse model of MS, contrasting with the moderate effect of each single mutation. Here, VAV1 is linked to myeloid sarcoma.